We are proud to be a woman-owned business that leads the world in the manufacturing of generic respiratory medications.
The FDA approved our first generic respiratory medication in 1997, and since then we’ve been committed to bringing safe, effective, and affordable medications to patients in need.
Our mission to improve patient outcomes has fueled our commitment to innovation, quality, and service.
We’ve invested in a state-of-the-art facility and industry-leading technology to expand our capacity to help patients.
We’ve opened an outsourcing division to help health care facilities that need 503B compounded drugs, often during drug shortages.
Our new facility also equips us to develop and bring new ophthalmic and injectable medications to market.
We’ve been leading the industry in safety and quality since our beginnings.
Just a few years after we introduced our first drug, we led the market in safety practices related to wrapping and barcoding medications.
Now, this approach is standard practice at U.S. hospitals. Today, we’re proud to use completely automated manufacturing, packaging, and distributing systems to minimize contamination.
Our people are the key to our success. We are proud to have the top minds in the industry who are committed to serving health professionals and patients.
We understand our responsibility to serve extends outside our facility, and even beyond the patient bedside, which is why we also prioritize giving back to our community and the next generation of innovators.